HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
- PMID: 12912907
- PMCID: PMC175782
- DOI: 10.1093/emboj/cdg392
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
Abstract
Hypoxia-inducible factor (HIF), a transcriptional complex conserved from Caenorhabditis elegans to vertebrates, plays a pivotal role in cellular adaptation to low oxygen availability. In normoxia, the HIF-alpha subunits are targeted for destruction by prolyl hydroxylation, a specific modification that provides recognition for the E3 ubiquitin ligase complex containing the von Hippel-Lindau tumour suppressor protein (pVHL). Three HIF prolyl-hydroxylases (PHD1, 2 and 3) were identified recently in mammals and shown to hydroxylate HIF-alpha subunits. Here we show that specific 'silencing' of PHD2 with short interfering RNAs is sufficient to stabilize and activate HIF-1alpha in normoxia in all the human cells investigated. 'Silencing' of PHD1 and PHD3 has no effect on the stability of HIF-1alpha either in normoxia or upon re-oxygenation of cells briefly exposed to hypoxia. We therefore conclude that, in vivo, PHDs have distinct assigned functions, PHD2 being the critical oxygen sensor setting the low steady-state levels of HIF-1alpha in normoxia. Interestingly, PHD2 is upregulated by hypoxia, providing an HIF-1-dependent auto-regulatory mechanism driven by the oxygen tension.
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f1.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f2a.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f2a.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f3.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f4.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f5.gif)
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/175782/bin/cdg392f6.gif)
Similar articles
-
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.J Biol Chem. 2004 Sep 10;279(37):38458-65. doi: 10.1074/jbc.M406026200. Epub 2004 Jul 7. J Biol Chem. 2004. PMID: 15247232
-
Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.J Cell Biochem. 2004 Jun 1;92(3):491-501. doi: 10.1002/jcb.20067. J Cell Biochem. 2004. PMID: 15156561
-
HIF hydroxylation and cellular oxygen sensing.Biol Chem. 2004 Mar-Apr;385(3-4):223-30. doi: 10.1515/BC.2004.016. Biol Chem. 2004. PMID: 15134335 Review.
-
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.Biochem J. 2004 Aug 1;381(Pt 3):761-7. doi: 10.1042/BJ20040620. Biochem J. 2004. PMID: 15104534 Free PMC article.
-
Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.IUBMB Life. 2001 Jul;52(1-2):43-7. doi: 10.1080/15216540252774757. IUBMB Life. 2001. PMID: 11795592 Review.
Cited by
-
Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis.Int J Nanomedicine. 2024 May 17;19:4377-4409. doi: 10.2147/IJN.S463333. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38774029 Free PMC article. Review.
-
Regulation of Cancer-Associated miRNAs Expression under Hypoxic Conditions.Anal Cell Pathol (Amst). 2024 May 10;2024:5523283. doi: 10.1155/2024/5523283. eCollection 2024. Anal Cell Pathol (Amst). 2024. PMID: 38766303 Free PMC article. Review.
-
Exposure to normobaric hypoxia shapes the acute inflammatory response in human whole blood cells in vivo.Pflugers Arch. 2024 May 7. doi: 10.1007/s00424-024-02969-2. Online ahead of print. Pflugers Arch. 2024. PMID: 38714572
-
Oxygen enhances antiviral innate immunity through maintenance of EGLN1-catalyzed proline hydroxylation of IRF3.Nat Commun. 2024 Apr 26;15(1):3533. doi: 10.1038/s41467-024-47814-3. Nat Commun. 2024. PMID: 38670937 Free PMC article.
-
Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study.Kidney Dis (Basel). 2024 Jan 3;10(2):132-142. doi: 10.1159/000536039. eCollection 2024 Apr. Kidney Dis (Basel). 2024. PMID: 38659701 Free PMC article. Review.
References
-
- Berra E., Richard,D.E., Gothié,E. and Pouysségur,J. (2001a) HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1α degradation. FEBS Lett., 491, 85–90. - PubMed
-
- Brondello J.M., Brunet,A., Pouysségur,J. and McKenzie,F.R. (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem., 272, 1368–1376. - PubMed
-
- Bruick R.K. and McKnight,S.L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337–1340. - PubMed
-
- Chan D.A., Sutphin,P.D., Denko,N.C. and Giaccia,A.J. (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem., 277, 40112–40117. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources